- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Jazz
Recent news which mentions Jazz
2 Incredible Growth Stocks That Are Screaming Buys for 2024
January 22, 2024
From Motley Fool
4 Remarkable Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
January 13, 2024
From Motley Fool
US Stocks Set To Open Weaker As Traders Eye Key Main Street Events: Analyst Sees Buying Opportunity On 'Stunning' Earnings Expectations
January 03, 2024
From Benzinga
7 Growth Stocks Poised to Thrive in a Post-Fed Pivot World
December 28, 2023
From InvestorPlace
Jazz Pharmaceuticals' Post-Traumatic Stress Disorder Drug Disappoints In Mid-Stage Study
December 22, 2023
From Benzinga
3 No-Brainer Stocks to Buy With $500 Right Now
December 20, 2023
From Motley Fool
Japan Approves Marijuana-Derived Medicines, Adopt 7-Year Prison Sentences For Recreational Use
December 06, 2023
Tickers
JAZZ
From Benzinga
Australian MPs Admit They Tried Cannabis, Signaling Policy Reform & Epidiolex For Seizures Approved In Canada
November 30, 2023
Tickers
JAZZ
From Benzinga
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
November 28, 2023
From InvestorPlace
3 Biotech Stocks That Could Be Millionaire Makers
November 22, 2023
From Motley Fool
Police Boss Turned Cannabis Reform Advocate, MMJ Legalization In Japan And More Global Updates
November 16, 2023
Tickers
JAZZ
From Benzinga
3 No-Brainer Stocks to Buy With $200 Right Now
November 15, 2023
From Motley Fool
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
November 09, 2023
From InvestorPlace
Cannabis Cash Burn Concerns? Sell These 7 Overbought Stocks Now.
November 07, 2023
From InvestorPlace
FDA Report On Its 50 Years In Cannabis Research, Signals A Boost In Medical Marijuana Prospects
November 03, 2023
From Benzinga
Ireland Reimburses Medical Marijuana-Based Drug For Chemotherapy-Induced Nausea And Vomiting
October 30, 2023
From Benzinga
Europe's High: UK Parents Need NHS Help For Daughter's Seizures, THC MMJ Flowers In Switzerland & More
October 24, 2023
From Benzinga
Cannabis Stocks Dip: How Rising Interest Rates Impact Your Portfolio
October 23, 2023
From Benzinga
Europe's High: Irish GPs Against Pot, Switzerland-Spain Share Data On Cannabis Clubs & More
October 20, 2023
Tickers
JAZZ
From Benzinga
Jazz Pharmaceuticals Explores Asset Sale Option, Possibly Cannabinoid Business: Report
October 20, 2023
Tickers
JAZZ
From Benzinga
I missed Beyoncé’s European tour, so I flew 4,600 miles to New Orleans to see her in concert — by myself
October 11, 2023
Tickers
JAZZ
From CNBC.com News
2 Top Biotech Stocks to Buy in October
October 03, 2023
From Motley Fool
5 Genius Safe Stocks to Buy for the 4th Quarter of 2023
October 02, 2023
From Motley Fool
4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
September 30, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.